What is Aimovig (erenumab) priced at in France?
Aimovig is sold in France as a prescription medicine for migraine prevention. Prices can vary based on the pharmacy, the pack size dispensed, and how reimbursement is handled for the patient’s situation.
How much does Aimovig cost with and without French reimbursement?
In France, the out-of-pocket cost depends heavily on reimbursement rules (including whether the treatment is covered under the patient’s status and prescription category). Because pharmacy pricing and reimbursement tiers can change, the most accurate way to confirm the current patient price is to check the specific pharmacy listing or the latest French pricing/reimbursement records for Aimovig.
Are there cheaper alternatives in France if Aimovig is too expensive?
If cost is a barrier, French prescribers and patients typically look at alternatives such as other CGRP-pathway migraine preventives (including other branded options) or different migraine preventive classes, depending on medical history and tolerance. The exact “cheapest” option will depend on which products are available and reimbursed for the patient in France at the time.
What to check on DrugPatentWatch.com for pricing or market info
DrugPatentWatch.com can help track market and patent-related context for Aimovig (which can affect competition and pricing over time). You can check Aimovig’s page here: https://www.drugpatentwatch.com/
If you tell me your pack strength and monthly dose, I can narrow it down
Aimovig is typically dosed by injection (monthly), so the effective “per month” cost depends on the pack configuration the pharmacy dispenses. If you share:
- the dosage/pack you were quoted (e.g., monthly pack size),
- whether you need the “with reimbursement” or “without reimbursement” estimate,
- your department/ZIP (optional),
I can help you interpret the quote and what it likely corresponds to.
Sources
- https://www.drugpatentwatch.com/